혈청 Gamma-Glutamyltransferase에 따른 복부비만과 제2형 다뇨병간의 관련성: Korean Genome and Epidemiology Study
The Association of Central Obesity with Type 2 Diabetes among Koreans according to the Serum Gamma-Glutamyltransferase Level: Korean Genome and Epidemiology Study
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives : This cross-sectional study was performed to examine if the serum gamma-glutamyltransferase (GGT) level that is within its normal range is associated with the risk of type 2 diabetes and if the association between the waist hip ratio (WHR) and type 2 diabetes is different depending on the serum GGT levels. Methods : The study subjects were 23,436 persons aged 40 years or older and who participated in regular health check-ups at 11 hospitals (males: 5,821, females: 17,615). The gender-specific quintiles of the serum GGT and WHR were used to examine the associations with type 2 diabetes. Results : The serum GGT levels within their normal range were positively associated with type 2 diabetes only in women. The adjusted odds ratios (ORs) were 1.0, 1.0, 1.4, 2.1, and 2.5 according to the quintiles of the serum GGT (ptrend<0.01). The WHR was more strongly associated with the prevalence of diabetes among the women with a highnormal serum GGT level as compared with those with a low-normal serum GGT level (p for interaction=0.02). For example, the adjusted ORs for women with a low normal serum GGT level were 1.0, 1.2, 1.5, 2.2, and 2.4 according to the quintiles of the WHR, while those figures were 1.0, 2.4, 3.6, 5.0, and 8.3 among the women with a high normal serum GGT level. However, in men, the serum GGT was very weakly associated with type 2 diabetes and the association between the WHR and type 2 diabetes was not different depending on the serum GGT level. Conclusions : Serum GGT within its normal range was positively associated with type 2 diabetes, and central obesity was more strongly associated with the prevalence of type 2 diabetes when the serum GGT level was highnormal. However, these associations were observed only in women, which is different from the previous findings. The stronger relation between central obesity and type 2 diabetes among women with a high-normal serum GGT level can be useful for selecting a group that is at high risk for type 2 diabetes irregardless of whatever the underlying mechanism is.
Abstract
Objectives : This cross-sectional study was performed to examine if the serum gamma-glutamyltransferase (GGT) level that is within its normal range is associated with the risk of type 2 diabetes and if the association between the waist hip ratio (WHR) and type 2 diabetes is different depending on the serum GGT levels. Methods : The study subjects were 23,436 persons aged 40 years or older and who participated in regular health check-ups at 11 hospitals (males: 5,821, females: 17,615). The gender-specific quintiles of the serum GGT and WHR were used to examine the associations with type 2 diabetes. Results : The serum GGT levels within their normal range were positively associated with type 2 diabetes only in women. The adjusted odds ratios (ORs) were 1.0, 1.0, 1.4, 2.1, and 2.5 according to the quintiles of the serum GGT (ptrend<0.01). The WHR was more strongly associated with the prevalence of diabetes among the women with a highnormal serum GGT level as compared with those with a low-normal serum GGT level (p for interaction=0.02). For example, the adjusted ORs for women with a low normal serum GGT level were 1.0, 1.2, 1.5, 2.2, and 2.4 according to the quintiles of the WHR, while those figures were 1.0, 2.4, 3.6, 5.0, and 8.3 among the women with a high normal serum GGT level. However, in men, the serum GGT was very weakly associated with type 2 diabetes and the association between the WHR and type 2 diabetes was not different depending on the serum GGT level. Conclusions : Serum GGT within its normal range was positively associated with type 2 diabetes, and central obesity was more strongly associated with the prevalence of type 2 diabetes when the serum GGT level was highnormal. However, these associations were observed only in women, which is different from the previous findings. The stronger relation between central obesity and type 2 diabetes among women with a high-normal serum GGT level can be useful for selecting a group that is at high risk for type 2 diabetes irregardless of whatever the underlying mechanism is.
참고문헌 (28)
- Brenner H, "Distribution, determinants, and prognostic value of gamma-glutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany", Prev Med, 26(3), pp.305~310 (1997)
- Nilssen O, "The Tromso Study: Distribution and population determinants of gamma-glutamyltransferase", Am J Epidemiol, 132(2), pp.318~326 (1990)
- 임지선, "정상 범위 내 혈청 GGT와 심혈관계질환의 위험요인과의 관련성", 예방의학회지, 38(1), pp.101~106 (2005), 대한예방의학회
- Lee DH, "is a predictor of incident diabetes and hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study", Clin Chem, 49(8), pp.1358~1366 (2003)
- Lee DH, "Gamma-glutamyltransferase and diabetes: A 4 year follow-up study", Diabetologia, 46(3), pp.359~364 (2003)
- Wannamethee G, "Gamma-glutamyltransferase: Determinants and association with mortality from ischemic heart disease and all causes", Am J Epidemiol, 142(7), pp.699~708 (1995)
- Perry IJ, "Prospective study of serum gamma-glutamyltransferase and risk of NIDDM", Diabetes Care, 21(5), pp.732~737 (1998)
- Nannipieri M, "Liver enzymes, the metabolic syndrome, and incident diabetes:The Mexico city diabetes study", Diabetes Care, 28(7), pp.1757~1762 (2005)
- Miura K, "Serum gammaglutamyl transferase level in predicting hypertension among male drinkers", J Hum Hypertens, 8(6), pp.445~449 (1994)
- Meisinger C, "Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population", J Intern Med, 258(6), pp.527~535 (2005)
- Ruttmann E, "Gammaglutamyltransferase as a risk factor for cardiovascular disease mortality: An epidemiological investigation in a cohort of 163,944 Austrian adults", Circulation, 112(14), pp.2130~2137 (2005)
- Lee DH, "Gammaglutamyltransferase, obesity, and the risk of type 2 diabetes: Observational cohort study among 20,158 middle-aged men and women", J Clin Endocrinol Metab, 89(11), pp.5410~5414 (2004)
- Andre P, "Threeyear increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: The D.E.S.I.R. cohort", Diabetologia, 49(11), pp.2599~2603 (2006)
- Jousilahti P, "Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke", Stroke, 31(8), pp.1851~1855 (2000)
- Mensah GA, "Obesity, metabolic syndrome, and type 2 diabetes:Emerging epidemics and their cardiovascular implications", Cardiol Clin, 22(4), pp.485~504 (2004)
- 류승호, "복부비만이 제2형 당뇨병 및 공복혈당장애 발생에 미치는 영향: 후향적 코호트 연구", 예방의학회지, 37(4), pp.359~365 (2004), 대한예방의학회
- Lim JS, "A strong interaction between serum gamma-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: Results from the Third National Health and Nutrition Examination Survey", Clin Chem, 53(6), pp.1092~1098 (2007)
- Huxley R, "Ethnic comparisons of obesity in the Asia-Pacific region: Protocol for a collaborative overview of cross-sectional studies", Obes Rev, 6(3), pp.193~198 (2005)
- Deurenberg P, "Asians are different from Caucasians and from each other in their body mass index", body fat per cent relationship, 2002, pp.3(3), 141~146
- Kim DJ, "Serum gammaglutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors", Diabet Med, 22(9), pp.1134~1140 (2005)
- Sabanayagam C, "Serum gamma-glutamyl transferase level and diabetes mellitus among US adults", Eur J Epidemiol, 24(7), pp.369~373 (2009)
- Zoppini G, "Relationship of serum gammaglutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes", Obesity (Silver Spring), 17(2), pp.370~374 (2009)
- Grundy SM, "Gamma-glutamyl transferase:Another biomarker for metabolic syndrome and cardiovascular risk", Arterioscler Thromb Vasc Biol, 27(1), pp.4~7 (2007)
- Marchesini G, "Nonalcoholic fatty liver disease: A feature of the metabolic syndrome", Diabetes, 50(8), pp.1844~1850 (2001)
- Lee DH, "Is serum gamma glutamyltransferase a marker of oxidative stress?", Free Radic Res, 38(6), pp.535~539 (2004)
- 신주연, "혈중 감마지티피 상승의 임상적 의의", 대한직업환경의학회지, 17(1), pp.1~9 (2005), 대한직업환경의학회
- Lee DH, "Association between serum concentrations of persistent organic pollutants and gamma glutamyltransferase:Results from the National Health and Examination Survey 1999-2002", Clin Chem, 52(9), pp.1825~1827 (2002)
- Lee DH, "A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes:Results from the National Health and Examination Survey 1999-2002", Diabetes Care, 29(7), pp.1638~1644 (2006)